Associated Papers
The ERK inhibitor GDC-0994 selectively inhibits growth of BRAF mutant cancer cells.
Chen Y et al.
Translational Oncology, 2024
38728872 (PubMed )
Supplement: mmc1.pdf
UVB mutagenesis differs in Nras- and Braf-mutant mouse models of melanoma.
Bowman RL et al.
Life Science Alliance, 2021
34210801 (PubMed )
Supplement: LSA-2021-01135_TableS1.xlsx › Supp._Table_S1
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
Macerola E et al.
Virchows Archiv : an International Journal of Pathology, 2015
Select a paper to view details